|Articles|October 1, 2016
- BioPharm International-10-01-2016
- Volume 29
- Issue 10
BioPharm International, October 2016 Issue (PDF)
Click the title above to open the BioPharm International October 2016 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 9 years ago
Defining Risk Assessment of Aseptic Processesover 9 years ago
Real Time Continuous Microbiological Monitoringover 9 years ago
Optimizing Temperature Control for Biopharmaceuticalsover 9 years ago
HPLE Sugars Improve Stability and Drug Productover 9 years ago
Calling All Authorsover 9 years ago
Multiparticulate technologies hot for controlled releaseover 9 years ago
New Drug-Delivery Methods: From Concept to Patientover 9 years ago
Manufacturers Face Major Changes under PDUFA VIover 9 years ago
Fill/Finish OutsourcingNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
New $82 Million Biopharma Launch Targets Rare Disease Development With AI-Driven Strategy
2
Next-Generation Modalities Drive New Antibody Discovery
3
Industry Outlook 2026: Biopharma Industry Confronts Skills Shortage with Strategic Automation (Part 2)
4
How Biopharma Navigates the 2026 Economic Shift
5
